PharmAthene Submits White Paper To BARDA For Advanced Development Funding For SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine

Sponsored Links

Main Menu

MedicalResources

PharmAthene Submits White Paper To BARDA For Advanced Development Funding For SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine

PDF

Print

E-mail

Medical News - Bio-terrorism

PharmAthene, Inc...

Read more: Bio-terrorism / Terrorism News From Medical News Today

< Prev		Next >